September 14, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Accuride Corporation (NYSE:ACW), was announced concerning whether the takeover of Accuride Corporation. For $2.58 per share is unfair to NYSE:ACW stockholders.

The investigation by a law firm concerns whether certain officers and directors of Accuride Corporation breached their fiduciary duties owed to NYSE:ACW investors in connection with the proposed acquisition.

On September 2, 2016, Accuride Corporation (NYSE:ACW) announced that it has entered into a definitive agreement to be acquired by funds managed by private equity firm Crestview Partners for $2.58 per share in cash.

However, given that investment funds affiliated with Cetus Capital LLC, who collectively hold approximately 17 percent of the outstanding Accuride shares, have already entered into a customary voting agreement to support the Crestview transaction, the investigation concerns whether the offer is unfair to NYSE:ACW stockholders. More specifically, the investigation concerns whether the Accuride Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.